+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Imipenem"

Carbapenem-Based Antibiotics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Carbapenem-Based Antibiotics Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 185 Pages
  • Global
From
4-AA for Carbapenem Antibiotic Market - Global Forecast 2026-2032 - Product Thumbnail Image

4-AA for Carbapenem Antibiotic Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 195 Pages
  • Global
From
From
Carbapenem - Global Strategic Business Report - Product Thumbnail Image

Carbapenem - Global Strategic Business Report

  • Report
  • November 2026
  • 383 Pages
  • Global
From
Carbapenem-Based Antibiotics Market Report 2026 - Product Thumbnail Image

Carbapenem-Based Antibiotics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
From
From
From
From
From
From
  • 15 Results (Page 1 of 1)
Loading Indicator

Imipenem is an antibiotic used to treat a wide range of bacterial infections. It belongs to a class of antibiotics known as carbapenems, which are used to treat serious infections caused by bacteria that are resistant to other antibiotics. Imipenem is typically used in combination with other antibiotics to treat infections such as pneumonia, urinary tract infections, and skin and soft tissue infections. It is also used to treat infections caused by certain types of bacteria that are resistant to other antibiotics. Imipenem is available in both oral and intravenous formulations. It is usually administered intravenously in the hospital setting, while oral formulations are available for outpatient use. Imipenem is generally well tolerated, but can cause side effects such as nausea, vomiting, and diarrhea. Imipenem is a widely used antibiotic and is available from many pharmaceutical companies. Some of the companies that produce imipenem include Merck, Pfizer, GlaxoSmithKline, and AstraZeneca. Show Less Read more